The Pharmaceutical Society of Australia (PSA) urges pharmacists applying for Recognition of Prior Learning (RPL) for the new Medication Management Review (MMR) Credential to submit all required evidence by 22 April 2025.
The 22 April 2025 deadline ensures applications are processed before interim funding arrangements end on 30 June.
PSA guarantees that pharmacists who submit a complete MMR RPL application before 22 April will have their RPL processed and new credential issued before 1 July.
Submission made after this date will still be processed, however, may not be completed before 1 July.
Pharmacists are reminded that from 1 July 2025, those who have not obtained a new credential will be unable to claim fees for MMR services, as current Medication Review Numbers (MRNs) will become invalid.
PSA continues to support consultant pharmacists by offering complimentary MMR RPL for professional plus members.
PSA National President Associate Professor Fei Sim FPS says the guarantee gives pharmacists certainty about their ability to continue providing MMR services uninterrupted.
“The temporary extension of MRNs meant that pharmacists had more time to transition to new credentials, minimising disruption to patient services and allowing the existing workforce to continue providing MMR services,” says Associate Professor Sim.
“As we now approach the end of this extension, our team is preparing for an influx of applications.
“To ensure that critical MMR services are not interrupted, PSA is guaranteeing that all RPL applications submitted before 22 April will be processed before 1 July.
“I strongly encourage pharmacists who have not yet enrolled in the RPL course and submitted the required evidence to do so as soon as possible, ensuring that your services are not interrupted on 1 July.”
PSA Consultant Pharmacist Community of Specialty Interest (CSI) Chair Deborah Hawthorne FPS CredPharm (MMR) also encourages pharmacists to connect with the CSI for support.
“As the temporary extension of our MRNs comes to an end, now is time to gather and submit evidence for your RPL,” says Ms Hawthorne.
“Our Consultant Pharmacists CSI Facebook group is a valuable resource for members undertaking RPL, particularly when it comes to the peer review process.
“I encourage PSA members to join our community and reach out to peers for support as we near 1 July.”
PSA has provided pharmacists detailed information and a step-by-step guide to submitting RPL evidence on a dedicated webpage, available here.
PSA’s credentialing team is also available to assist learners via credentialing@psa.org.au.
